Amongst the other differentially expressed FABPs, FABP4 was released from adipocytes, implicated in obesity [36] and its possible involvement in the malignant progression of prostate cancer has been investigated previously [37]. Here, FABP4 is linked to obesity due to melanocortin 4 receptor deficiency.